This federal contract award, valued at $34,000, was issued by the U.S. Department of Veterans Affairs (VA) to Edwards Lifesciences LLC, a for-profit limited liability company and subsidiary of Edwards Lifesciences Corporation. The contract is for the provision of TAVR (Transcatheter Aortic Valve Replacement) products and is structured as a firm fixed-price purchase order. It has an ultimate completion date of June 20, 2025. Edwards Lifesciences LLC is a global leader in medical innovations for structural heart disease and critical care monitoring, and this contract supports the VA's and Veterans Health Administration's (VHA) efforts to enhance surgical and cardiovascular care for veterans. The company also holds a significant Indefinite Delivery Contract (IDV) with the VA, specifically with Veterans Integrated Service Network 19, valued at $1,190,000 through December 22, 2029, as well as a Blanket Purchase Agreement with the VA-VHA, valued at $1,590,000, allowing medical centers within Veterans Integrated Service Network 21 to order various Edwards heart valve models through 2028. This contract award does not have a set-aside designation.
Generated 4/22/25, 12:08 PM